Fevertree shares are down 65% this year. Is it time to buy?

Fevertree shares have tanked in 2022. Yet the company continues to grow. Is this a good buying opportunity? Edward Sheldon takes a look.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Risk reward ratio / risk management concept

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Fevertree (LSE:FEVR) shares have experienced a major collapse in 2022. Year to date, shares in the premium mixer drinks business are down about 65%.

Is this a great buying opportunity for me? Or are there better growth stocks to buy for my portfolio today? Let’s discuss.

Two reasons to be bullish on Fevertree

I can see a few reasons to be bullish on Fevertree shares today. For a start, the company continues to generate solid top-line growth. For the six months to the end of June, for example, revenue came in at £160.9m, up 14% year on year (growth in Europe was up an impressive 27% year on year).

And management remains confident about the growth story going forward. “The long-term opportunity for the business remains very significant,” said CEO Tim Warrilow in the company’s H1 results. “As the global leader of the premium mixer category we remain at the center of the well-established trends to premiumisation and long-mixed drinks,” he added.

Secondly, several company insiders have purchased stock recently. Regulatory filings show that in late September and early October, board members Jeff Popkin and Kevin Havelock invested around £680,000 in Fevertree shares. Popkin and Havelock each have over 25 years experience in the beverage industry. The former is currently North American CEO of Mast-Jägermeister, while the latter is currently global president, Refreshment at Unilever. So these insiders are likely to have a good understanding of Fevertree’s prospects. I see their buying activity as a positive development.

The shares aren’t cheap

Having said that, Fevertree shares are still quite expensive, even after their recent decline. This is due to the fact that the company’s profits have been squeezed by industry-wide inflationary pressures.

Currently, City analysts expect Fevertree to generate earnings per share of 21.5p for this year and 25.9p for next year. This means that at the current share price of 929p, the forward-looking price-to-earnings (P/E) ratio here is 43, falling to 36 using next year’s earnings forecast. These multiples seem quite high to me. I think buying the stock at these valuations is quite risky. If growth stalls, or earnings come in below expectations, the stock could head lower.

It’s worth noting here that Financial Conduct Authority data shows that the stock has quite a high level of short interest (6.5%) right now. This indicates that hedge funds and other sophisticated investors are betting that Fevertree’s share price will fall. I generally avoid buying stocks that are heavily shorted as research shows that these stocks tend to underperform.

My move now

Given the high valuation and the level of short interest here, I’m going to leave Fevertree shares on my watchlist for now. For me, the risk/reward proposition is not so attractive. All things considered, I think there are better growth stocks to buy for my portfolio today.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has positions in Unilever. The Motley Fool UK has recommended Fevertree Drinks and Unilever. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »